Skip to main content
. 2023 Jun 28;15(13):2940. doi: 10.3390/nu15132940

Table 3.

Dietary patterns and risk of colorectal neoplasms, overall and subclassified by gut microbiota enterotypes a.

Group Healthy Pattern p b pheterogeneity c High-Fat Pattern p b pheterogeneity c
Quartile 1 Quartile 2 Quartile 3 Quartile 1 Quartile 2 Quartile 3
Control (N = 160)
   No. (%) 56 (35.0) 52 (32.5) 52 (32.5) 59 (36.9) 51 (31.9) 50 (31.2)
All colorectal cancer (N = 130)
   No. (%) 80 (61.5) 24 (18.5) 26 (20.0) <0.001 53 (40.8) 36 (27.7) 41 (31.5) 0.704
   Multivariable-adjusted OR (95% CI) d 1 (Referent) 0.36
(0.19 to 0.66)
0.38
(0.2 to 0.71)
0.001 1 (Referent) 0.80
(0.45 to 1.44)
0.99
(0.55 to 1.76)
0.925
Type I colorectal cancer (N = 68) 0.644 0.636
   No. (%) 39 (57.4) 12 (17.6) 17 (25.0) 0.006 (type I vs. II) 31 (45.6) 15 (22.1) 22 (32.3) 0.283 (type I vs. II)
   Multivariable-adjusted OR (95% CI) d 1 (Referent) 0.40
(0.18 to 0.86)
0.52
(0.25 to 1.11)
0.054 1 (Referent) 0.62
(0.30 to 1.31)
0.97
(0.48 to 1.95)
0.824
Type II colorectal cancer (N = 48) 0.046 0.139
   No. (%) 35 (72.9) 7 (14.6) 6 (12.5) <0.001 (type II vs. III) 20 (41.7) 15 (31.2) 13 (27.1) 0.803 (type II vs. III)
   Multivariable-adjusted OR (95% CI) d 1 (Referent) 0.21
(0.09 to 0.52)
0.19
(0.07 to 0.48)
<0.001 1 (Referent) 0.84
(0.39 to 1.83)
0.69
(0.31 to 1.55)
0.369
Type III colorectal cancer (N = 14) 0.049 0.219
   No. (%) 6 (42.9) 5 (35.7) 3 (21.4) 0.683 (type I vs. III) 2 (14.3) 6 (42.9) 6 (42.9) 0.236 (type I vs. III)
   Multivariable-adjusted OR (95% CI) d 1 (Referent) 0.8
(0.22 to 2.85)
0.51
(0.12 to 2.19)
0.722 1 (Referent) 3.22
(0.61 to 16.91)
3.26
(0.62 to 17.18)
0.179
All colorectal adenoma (N = 120)
   No. (%) 59 (49.2) 26 (21.7) 35 (29.2) 0.039 45 (37.5) 36 (30.0) 39 (32.5) 0.942
   Multivariable-adjusted OR (95% CI) d 1 (Referent) 0.48
(0.27 to 0.88)
0.67
(0.38 to 1.18)
0.120 1 (Referent) 0.90
(0.50 to 1.60)
0.97
(0.54 to 1.73)
0.901
Type I colorectal adenoma (N = 50) 0.643 0.927
   No. (%) 27 (54.0) 12 (24.0) 11 (22.0) 0.056 (type I vs. II) 21 (42.0) 12 (24.0) 17 (34.0) 0.565 (type I vs. II)
   Multivariable-adjusted OR (95% CI) d 1 (Referent) 0.48
(0.22 to 1.06)
0.44
(0.20 to 0.99)
0.033 1 (Referent) 0.62
(0.27 to 1.39)
0.88
(0.42 to 1.88)
0.710
Type II colorectal adenoma (N = 52) 0.030 0.438
   No. (%) 26 (50.0) 12 (23.1) 14 (26.9) 0.147 (type II vs. III) 22 (42.3) 13 (25.0) 17 (32.7) 0.624 (type II vs. III)
   Multivariable-adjusted OR (95% CI) d 1 (Referent) 0.46
(0.20 to 1.05)
0.50
(0.23 to 1.09)
0.068 1 (Referent) 0.58
(0.26 to 1.31)
0.94
(0.44 to 1.99)
0.804
Type III colorectal adenoma (N = 18) 0.013 0.477
   No. (%) 6 (33.3) 2 (11.1) 10 (55.6) 0.085 (type I vs. III) 2 (11.1) 11 (61.1) 5 (27.8) 0.028 (type I vs. III)
   Multivariable-adjusted OR (95% CI) d 1 (Referent) 0.30
(0.06 to 1.62)
1.63
(0.53 to 4.98)
0.295 1 (Referent) 6.38
(1.33 to 30.7)
2.67
(0.49 to 14.55)
0.346

Abbreviations: CI, confidence interval; OR, odds ratio. a The colorectal cancer and colorectal adenoma groups were divided into three enterotypes (or subtypes), labeled as type I, type II, and type III, based on their gut microbiota profiles, using the Dirichlet multinomial mixture model. b The p values represent the comparison between the case group (colorectal cancer or adenoma, including their subtypes) and the control group, either in the univariate or multivariate analysis. In the multivariate analysis, p values were determined by the linear trend test, which utilized multivariable logistic regression. c The pheterogeneity value represents a test for heterogeneity to assess whether there is a significant difference in the association between dietary patterns and the risk of different subtypes of colorectal tumors. d The multivariable odds ratio (OR) was adjusted for potential risk factors with p-values less than 0.1 in the univariate analysis.